Latest News
- Rosacea
Thursday, March 28, 2019
Meet JOULE X and More New Offerings from Sciton at ASLMS
Sciton Inc. unveiled JOULE X and other new offerings at the annual American Society for Laser Medicine and Surgery Meeting in Denver, Colorado. An upgrade to the JOULE platform, JOULE X is the…
Read the full storyWednesday, March 20, 2019
Are Skin Diseases More Common Than Previously Held?
Skin diseases may be more common than previously believed, according to a new study in the Journal of the European Academy of Dermatology and Venereology that estimates the prevalence of skin diseases…
Read the full storyMonday, March 11, 2019
Calling All Students: Ortho Dermatologics Now Accepting Applications for the 2019 Aspire Higher Scholarship Program
Ortho Dermatologics is accepting applications for its 2019 Aspire Higher scholarship program, which will award $90,000 total in scholarships to nine students who have been treated for a dermatologic c…
Read the full storyTuesday, March 05, 2019
Get to Know the Dermatology Hall of Fame's 2019 Inaugural Class of Inductees
The 10 individuals inducted into the Dermatology Hall of Fame’s 2019 Inaugural Class are: Albert Bernard Ackerman, M.D., the author of “Histologic Diagnosis of Inflammatory Skin Disease…
Read the full story
Wednesday, January 16, 2019
Dermatologists Prescribe the Most Antibiotics, But Usage Is Changing
The use of antibiotics to treat inflammatory skin conditions like acne and rosacea is decreasing over time, but there has been an increase in prescriptions associated with dermatologic surgical proced…
Read the full story
Wednesday, December 19, 2018
National Rosacea Society: New Grants Available in 2019
The National Rosacea Society (NRS) has new grants available in 2019 to support research into potential causes and other key aspects of rosacea that may lead to improvements in its management, preventi…
Read the full story
Wednesday, October 17, 2018
Aclaris Acquires Rhofade from Allergan
Aclaris Therapeutics, Inc. has entered into a definitive asset purchase agreement with Allergan Sales, LLC to acquire worldwide rights to Rhofade® (oxymetazoline hydrochloride) cream, 1% and addit…
Read the full storyTuesday, September 18, 2018
Experts Call for Improved Identification of "High Burden" Rosacea Patients in Everyday Practice
Additional analysis of a global survey conducted and presented earlier this year, as an expert-authored report called Rosacea: Beyond the visible, assists healthcare professionals in identifying the c…
Read the full story
Tuesday, August 14, 2018
Burt’s Bees Nature-Based Sensitive Skin Care Outperforms MD-Recommended Regimen
Burt’s Bees nature-based sensitive skin regimen is well-tolerated as well as clinically and statistically superior to a leading dermatologist-recommended synthetic regimen, according to a s…
Read the full story
Friday, August 03, 2018
Almirall to Acquire Allergan’s US Medical Dermatology Unit
Almirall is acquiring a portfolio of five products from Allergan’s Medical Dermatology unit in the United States, conditional to the clearance by the relevant authorities. The portfolio includes…
Read the full story
Wednesday, August 01, 2018
IRB Approval Means BioPharmX To Move Ahead on Phase 2 Trial of BPX-04 for Rosacea
BioPharmX Corporation has received Institutional Review Board approval for its phase 2 study of BPX-04 for the treatment of papulopustular rosacea. Based on data from its open-label feasibility study …
Read the full story
Tuesday, July 31, 2018
LEO Pharma to Acquire Bayer Prescription Dermatology Business
LEO Pharma has entered into a definitive agreement to buy Bayer's global prescription dermatology unit. The portfolio to be acquired includes branded topical prescription treatments for acne, fung…
Read the full story
Thursday, July 26, 2018
Link Between Diet and Skin Disease Takes Center Stage at Summer AAD
Dermatologists must help patients determine if there are any foods that may cause their skin condition to flare and provide evidence-based recommendations about next steps. “People looki…
Read the full storyWednesday, July 11, 2018
About 415 Million People May Have Rosacea Worldwide
As many as 415 million people worldwide may have rosacea, according to new research in the British Journal of Dermatology. Dr. Jacob Thyssen and colleagues at the University of Copenhagen, Denmark,…
Read the full story
Friday, June 08, 2018
Galderma Global Survey Assesses Burden of Rosacea
Recently released findings from Galderma’s global survey on the true burden of rosacea suggest a need for dermatologists and doctors to proactively open a dialogue with patie…
Read the full story
